Tocoyena sellowiana extract decreases bone loss in an experimental model of periodontitis in rats: Putative role for cyclooxygenase-2 and IL-1β inhibition - 04/02/18
pages | 10 |
Iconographies | 10 |
Vidéos | 0 |
Autres | 0 |
Graphical abstract |
Highlights |
• | Periodontitis is an inflammatory disease and causes periodontal tissue breakdown. |
• | Tocoyena sellowiana is largely used in Brazil as a medicinal plant. |
• | Tocoyena sellowiana decreased bone loss, MPO, IL-1β levels, and COX-2 immunostaining. |
• | Tocoyena sellowiana did not alter organs and body weight. |
Abstract |
Tocoyena sellowiana (Cham. & Schltdl.) K.Schum is one of the most important families of Brazilian medicinal plants. This study aimed to evaluate the effect of Tocoyena sellowiana (Cham. & Schltdl.) K.Schum ethanolic extract in a pre-clinical trial of periodontitis and to investigate possible mechanisms underlying such effects. Periodontitis was induced in Wistar rats by placing a nylon thread ligature around second upper left molars for 11 days. Rats received (per os) Tocoyena sellowiana (0.1, 1 or 10 mg kg) or vehicle 1 h before ligature and daily until day 11. Macroscopic, histopathological, and COX-2 immunohistochemical analyses were performed to evaluate the periodontium. The gingival tissue was used to quantify the myeloperoxidase (MPO) activity and interleukin (IL)-1β levels by ELISA. Blood samples were collected to evaluate bone-specific alkaline phosphatase (BALP), the dosage of creatinine, aspartate and alanine transaminases. The liver, kidneys, spleen, and body mass variations were also evaluated. Tocoyena sellowiana decreased bone loss, reduced MPO, IL-1β levels as well as COX-2 immunostaining, and increased BALP activity. Moreover, Tocoyena sellowiana did not alter organs nor body weight. Tocoyena sellowiana reduced bone loss in rats and its efficacy was at least partially dependent upon both IL-1β and cyclooxygenase-2 inhibition.
Le texte complet de cet article est disponible en PDF.Keywords : Tocoyena sellowiana, Periodontitis, Sub-chronic toxicity
Plan
Vol 98
P. 863-872 - février 2018 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?